Title
|
FOA/Notice Number
|
Related |
Issuing Org
|
Released ▼
|
Opens
|
Expires
|
Activity Code
|
Lung Transplant Consortium - Data Coordinating Center (U24 - Clinical Trial Not Allowed) |
RFA-HL-22-003 |
Related |
NHLBI
| 02-25-2021 |
05-15-2021 |
06-16-2021 |
U24 |
Lung Transplant Consortium - Clinical Centers (U01 - Clinical Trial Not Allowed) |
RFA-HL-22-002 |
Related |
NHLBI
| 02-25-2021 |
05-15-2021 |
06-16-2021 |
U01 |
NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Coordination and Evaluation Center (U24 Clinical Trial Not Allowed) |
RFA-RM-21-019 |
Related |
RMOD
| 02-24-2021 |
03-23-2021 |
04-24-2021 |
U24 |
NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not Allowed) |
RFA-DE-22-001 |
Related |
NIDCR
| 02-24-2021 |
06-08-2021 |
07-27-2021 |
R35 |
Mental Health Research Awards for Investigators Early in their Career in Low and Middle-Income Countries (R01 Clinical Trial Optional) |
RFA-MH-21-120 |
Related |
NIMH
| 02-23-2021 |
10-14-2021 |
11-16-2021 |
R01 |
Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite Resource and Coordinating Center (U24 Clinical Trial Required) |
RFA-HL-22-008 |
Related |
NHLBI
| 02-22-2021 |
05-11-2021 |
06-12-2021 |
U24 |
Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite Clinical Centers (Collaborative UG3/UH3 Clinical Trial Required) |
RFA-HL-22-007 |
Related |
NHLBI
| 02-22-2021 |
05-11-2021 |
06-12-2021 |
UG3/UH3 |
Limited Competition: Facility and Building System Upgrades Support for the Regional Biocontainment Laboratories (G20 Clinical Trial Not Allowed) |
RFA-AI-21-022 |
Related |
NIAID
| 02-19-2021 |
03-16-2021 |
04-17-2021 |
G20 |
Immune Cell Engineering For Targeted Therapy And Disease Monitoring in Type 1 Diabetes (R01 Clinical Trial Not Allowed) |
RFA-DK-21-005 |
Related |
NIDDK
| 02-19-2021 |
05-22-2021 |
06-23-2021 |
R01 |
Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) |
RFA-CA-21-030 |
Related |
NCI
| 02-19-2021 |
05-02-2021 |
06-03-2021 |
U01 |
Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33 Clinical Trial Not Allowed) |
RFA-AI-21-007 |
Related |
NIAID
| 02-19-2021 |
05-30-2021 |
07-01-2021 |
R61/R33 |
Renewal : UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (U01) Clinical Trials Optional |
RFA-FD-21-017 |
Related |
FDA
| 02-17-2021 |
02-25-2021 |
05-26-2021 |
U01 |
Fogarty Global Trauma and Injury Research Training Program (D43 Clinical Trial Optional) |
RFA-TW-21-003 |
Related |
FIC
| 02-17-2021 |
03-16-2021 |
04-17-2021 |
D43 |
Alliance to Support Integrated Public Health System Activities (U2F) Clinical Trials Not Allowed |
RFA-FD-21-029 |
Related |
FDA
| 02-17-2021 |
02-22-2021 |
04-24-2021 |
U2F |
Tobacco Regulatory Science (R01 Clinical Trial Optional) |
RFA-OD-21-002 |
Related |
NIH
| 02-17-2021 |
06-14-2021 |
02-15-2023 |
R01 |
Training Alliance to Enhance Produce Safety and FDA Food Safety Modernization Act Compliance (U2F) Clinical Trial Not Allowed |
RFA-FD-21-024 |
Related |
FDA
| 02-17-2021 |
02-17-2021 |
04-20-2021 |
U2F |
Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01) Clinical Trials Not Required |
RFA-FD-22-001 |
Related |
FDA
| 02-17-2021 |
12-17-2021 |
02-14-2024 |
R01 |
Dermal Physiologically-based Pharmacokinetic (PBPK) Models Accounting for the Absorption and Evaporation of Vehicle/Co-solvent following the Application of Generic Dermatological Products (U01) Clinical Trial Optional |
RFA-FD-21-019 |
Related |
FDA
| 02-16-2021 |
02-22-2021 |
04-23-2021 |
U01 |
Impulse Oscillometry Endpoint Sensitivity to Regional Lung Function Changes using Computational Fluid Dynamics (CFD) (U01) Clinical Trial Required |
RFA-FD-21-020 |
Related |
FDA
| 02-16-2021 |
02-24-2021 |
04-27-2021 |
U01 |
Basic Research to Inform Vaccine and Therapeutic Development for Non-Polio Human Enteroviruses (NPEV) (R01 Clinical Trial Not Allowed) |
RFA-AI-21-006 |
Related |
NIAID
| 02-12-2021 |
06-13-2021 |
07-14-2021 |
R01 |
Human Immunology Project Consortium (HIPC) Coordinating Center (U01 Clinical Trial Not Allowed) |
RFA-AI-20-080 |
Related |
NIAID
| 02-08-2021 |
05-04-2021 |
06-05-2021 |
U01 |
Human Immunology Project Consortium (U19 Clinical Trial Optional) |
RFA-AI-20-079 |
Related |
NIAID
| 02-08-2021 |
05-04-2021 |
06-05-2021 |
U19 |
Expert-Driven Small Projects to Strengthen Gabriella Miller Kids First Discovery (R03 Clinical Trial Not Allowed) |
RFA-RM-21-011 |
Related |
RMOD
| 02-08-2021 |
05-18-2021 |
06-19-2021 |
R03 |
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed) |
RFA-AA-21-003 |
Related |
NIAAA
| 02-05-2021 |
03-14-2021 |
04-15-2021 |
R03 |
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed) |
RFA-AA-21-002 |
Related |
NIAAA
| 02-05-2021 |
03-14-2021 |
04-15-2021 |
R01 |
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed) |
RFA-AA-21-004 |
Related |
NIAAA
| 02-05-2021 |
03-14-2021 |
04-15-2021 |
R21 |
High-throughput Discovery and Validation of Novel Signal Transducers or Small Molecules that Modulate Opioid or other Substance Use Disorder Relevant Pathways (R01 - Clinical Trials Not Allowed) |
RFA-DA-22-006 |
Related |
NIDA
| 02-04-2021 |
08-15-2021 |
09-16-2021 |
R01 |
Early-Phase Clinical Trials of Novel Interventions to Prevent, Delay, or Treat Aging-Related Conditions by Targeting Aging-Related Mechanisms (U01 Clinical Trial Required) |
RFA-AG-22-011 |
Related |
NIA
| 02-03-2021 |
05-17-2021 |
06-18-2021 |
U01 |
Screening for Conditions by Electronic Nose Technology (SCENT) (U01 Clinical Trial Optional) |
RFA-TR-21-009 |
Related |
NCATS
| 02-03-2021 |
05-10-2021 |
06-11-2021 |
U01 |
Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed) |
RFA-DA-22-004 |
Related |
NIDA
| 02-02-2021 |
06-14-2021 |
07-15-2022 |
R61/R33 |
The Cellular Scale Connectome in Aging and Alzheimers Disease (U01 Clinical Trial Not Allowed) |
RFA-AG-22-008 |
Related |
NIA
| 01-29-2021 |
05-15-2021 |
06-16-2021 |
U01 |
NIH Blueprint for Neuroscience Research: Tools and Technologies to Explore Nervous System Biomolecular Condensates (R21 Clinical Trial Not Allowed) |
RFA-DA-22-008 |
Related |
NIDA
| 01-25-2021 |
08-15-2021 |
09-16-2021 |
R21 |
Advancing Conformance with the Voluntary National Retail Food Regulatory Program Standards (VNRFRPS) by State, Local, Tribal, and Territorial (SLTT) Retail Food Regulatory Agencies (U2F) Clinical Trials Not Allowed |
RFA-FD-21-028 |
Related |
FDA
| 01-21-2021 |
01-19-2021 |
03-23-2021 |
U2F |
Nutrition for Precision Health, powered by the All of Us Research Program: Research Coordinating Center (U24 Clinical Trial Not Allowed) |
RFA-RM-21-006 |
Related |
RMOD
| 01-21-2021 |
03-05-2021 |
04-07-2021 |
U24 |
Nutrition for Precision Health, powered by the All of Us Research Program: Clinical Centers (UG1 Clinical Trial Required) |
RFA-RM-21-005 |
Related |
RMOD
| 01-21-2021 |
03-05-2021 |
04-07-2021 |
UG1 |
Nutrition for Precision Health, powered by the All of Us Research Program: Artificial Intelligence for Multimodal Data Modeling and Bioinformatics Center (U54 Clinical Trial Not Allowed) |
RFA-RM-21-001 |
Related |
RMOD
| 01-21-2021 |
03-05-2021 |
04-07-2021 |
U54 |
Nutrition for Precision Health, powered by the All of Us Research Program: Dietary Assessment Center (U24 Clinical Trial Optional) |
RFA-RM-21-004 |
Related |
RMOD
| 01-21-2021 |
03-05-2021 |
04-07-2021 |
U24 |
Nutrition for Precision Health, powered by the All of Us Research Program: Microbiome and Metagenomics Center (U24 Clinical Trial Not Allowed) |
RFA-RM-21-003 |
Related |
RMOD
| 01-21-2021 |
03-05-2021 |
04-07-2021 |
U24 |
Nutrition for Precision Health, powered by the All of Us Research Program: Metabolomics and Clinical Assays Center (U24 Clinical Trial Not Allowed) |
RFA-RM-21-002 |
Related |
RMOD
| 01-21-2021 |
03-05-2021 |
04-07-2021 |
U24 |
Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Optional) |
RFA-TR-21-008 |
Related |
NCATS
| 01-15-2021 |
03-19-2021 |
04-20-2021 |
UG3/UH3 |
BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) |
RFA-EY-21-001 |
Related |
NEI
| 01-15-2021 |
04-02-2021 |
10-28-2023 |
R21 |
Infectious Etiology of Alzheimer's Disease (R01 Clinical Trial Optional) |
RFA-AG-21-034 |
Related |
NIA
| 01-15-2021 |
02-28-2021 |
04-01-2021 |
R01 |
Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required) |
RFA-TR-21-010 |
Related |
NCATS
| 01-13-2021 |
03-13-2021 |
01-13-2022 |
U44 |
Biomarkers for Diabetic Foot Ulcers through the Diabetic Foot Consortium (R61/R33 Clinical Trial Not Allowed) |
RFA-DK-21-001 |
Related |
NIDDK
| 01-13-2021 |
03-22-2021 |
11-04-2021 |
R61/R33 |
Renewal - Elucidating the Sensorial and Functional Characteristics of Compositionally Different and Differently Aged Topical Formulations (U01) Clinical Trial Required |
RFA-FD-21-021 |
Related |
FDA
| 01-13-2021 |
01-18-2021 |
03-19-2021 |
U01 |
INTUIT-PC: Improving Nonsurgical Treatment of Urinary Incontinence among women in Primary Care: Dissemination and Implementation of PCOR Evidence (U18) |
RFA-HS-21-001 |
Related |
AHRQ
| 01-13-2021 |
01-13-2021 |
03-25-2021 |
U18 |
Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed) |
RFA-AI-20-078 |
Related |
NIAID
| 01-12-2021 |
05-04-2021 |
06-05-2021 |
U19 |
Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed) |
RFA-AI-20-077 |
Related |
NIAID
| 01-12-2021 |
05-04-2021 |
06-05-2021 |
U01 |
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required) |
RFA-DA-21-030 |
Related |
NIDA
| 01-11-2021 |
02-26-2021 |
03-27-2021 |
RM1 |
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Coordination and Dissemination Center (R24 Clinical Trial Optional) |
RFA-DA-21-029 |
Related |
NIDA
| 01-11-2021 |
02-26-2021 |
03-27-2021 |
R24 |
HEAL Initiative: Optimizing Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional) |
RFA-MH-21-145 |
Related |
NIMH
| 01-11-2021 |
02-18-2021 |
03-19-2021 |
R01 |
HEAL Initiative: HEALthy Brain and Child Development Consortium Administrative Core (U24 - Clinical Trial Not Allowed) |
RFA-DA-21-022 |
Related |
NIDA
| 01-11-2021 |
03-01-2021 |
04-01-2021 |
U24 |
HEAL Initiative: HEALthy Brain and Child Development Data Coordinating Center (U24) |
RFA-DA-21-023 |
Related |
NIDA
| 01-11-2021 |
03-01-2021 |
04-01-2021 |
U24 |
HEAL Initiative: HEALthy Brain and Child Development Study (U01 - Clinical Trial Not Allowed) |
RFA-DA-21-021 |
Related |
NIDA
| 01-11-2021 |
03-01-2021 |
04-01-2021 |
U01 |
HEAL Initiative: HEALthy Brain and Child Development Study (Collaborative U01- Clinical Trial Not Allowed) |
RFA-DA-21-020 |
Related |
NIDA
| 01-11-2021 |
03-01-2021 |
04-01-2021 |
U01 |
HEAL Initiative: Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial - Clinical Sites (UG1 Clinical Trial Required) |
RFA-HD-21-031 |
Related |
NICHD
| 01-11-2021 |
02-28-2021 |
03-31-2021 |
UG1 |
HEAL Initiative: Data Coordinating Center for the Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial (U24 Clinical Trial Required) |
RFA-HD-21-032 |
Related |
NICHD
| 01-11-2021 |
02-28-2021 |
03-31-2021 |
U24 |
Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Aging and Alzheimer's Disease (R01 Clinical Trial Not Allowed) |
RFA-AG-21-033 |
Related |
NIA
| 01-08-2021 |
02-18-2021 |
03-19-2021 |
R01 |
Tuberculosis Research Advancement Centers (P30 Clinical Trials Not Allowed) |
RFA-AI-21-001 |
Related |
NIAID
| 01-07-2021 |
05-15-2021 |
06-16-2021 |
P30 |
Development of a model selection method for population pharmacokinetics analysis by deep-learning based reinforcement learning (U01) Clinical Trials Not Allowed |
RFA-FD-21-027 |
Related |
FDA
| 01-07-2021 |
01-18-2021 |
03-19-2021 |
U01 |
Quantify the expression of metabolizing enzymes and transporter proteins in lung, eye and skin tissue in relevant animal models and humans (U01) Clinical Trial Not Allowed |
RFA-FD-21-018 |
Related |
FDA
| 01-07-2021 |
01-15-2021 |
03-16-2021 |
U01 |
Development of Advanced Analytical Methods for the Characterization of Iron Carbohydrate Complex - Ferric Derisomaltose (U01) Clinical Trials Not Allowed |
RFA-FD-21-016 |
Related |
FDA
| 01-07-2021 |
01-18-2021 |
04-01-2021 |
U01 |
Limited Competition: Revision to the Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required) |
RFA-DK-20-508 |
Related |
NIDDK
| 01-07-2021 |
03-14-2021 |
04-15-2021 |
U01 |
Computational Fluid Dynamics (CFD) Models to Aid the Development of Generic Inhalation Products (U01) Clinical Trials Optional |
RFA-FD-21-015 |
Related |
FDA
| 01-06-2021 |
01-12-2021 |
03-16-2021 |
U01 |
Physiologically Based Pharmacokinetic (PBPK) Models of Oral Absorption to Simulate the Results of Bioequivalence Studies (U01) Clinical Trials Optional |
RFA-FD-21-012 |
Related |
FDA
| 01-06-2021 |
01-15-2021 |
03-16-2021 |
U01 |
Next Generation Sequencing in Post Mortem Tissue from Patients with Parkinsons Disease (U01 Clinical Trial Not Allowed) |
RFA-NS-21-017 |
Related |
NINDS
| 01-06-2021 |
02-15-2021 |
03-16-2021 |
U01 |
Pilot and Feasibility Studies to Facilitate the Use of Diabetes Self-Management Education and Support to Improve Diabetes Care (R34 Clinical Trial Required) |
RFA-DK-20-032 |
Related |
NIDDK
| 01-06-2021 |
05-22-2021 |
06-23-2023 |
R34 |
Understanding and Reducing Cardiovascular Disease in Type 1 Diabetes Mellitus (R01 Clinical Trial Optional) |
RFA-HL-21-014 |
Related |
NHLBI
| 01-06-2021 |
02-15-2021 |
10-16-2021 |
R01 |
Cellular Senescence Network: Consortium Organization and Data Coordinating Center (U24 Clinical Trial Not Allowed) |
RFA-RM-21-010 |
Related |
RMOD
| 01-06-2021 |
02-22-2021 |
03-23-2021 |
U24 |
Cellular Senescence Network: Technology Development and Application (UG3/UH3 Clinical Trial Not Allowed) |
RFA-RM-21-009 |
Related |
RMOD
| 01-06-2021 |
02-22-2021 |
03-23-2021 |
UG3/UH3 |
Cellular Senescence Network: Tissue Mapping Centers (U54 Clinical Trial Not Allowed) |
RFA-RM-21-008 |
Related |
RMOD
| 01-06-2021 |
02-22-2021 |
03-23-2021 |
U54 |
New Approaches to Identify Neurogenesis and Study its Dynamics in Brain Aging and AD/ADRD (R01 Clinical Trial Not Allowed) |
RFA-AG-22-006 |
Related |
NIA
| 01-04-2021 |
05-17-2021 |
06-18-2021 |
R01 |
Improving Health Disparities in Alcohol Health Services (R01 Clinical Trial Optional) |
RFA-AA-21-001 |
Related |
NIAAA
| 12-28-2020 |
02-15-2021 |
03-16-2021 |
R01 |
Novel Approaches to Decrease Stigma of Substance Use Disorders in order to Facilitate Prevention, Treatment, and Support During Recovery (R43/R44 - Clinical Trials Optional) |
RFA-DA-21-016 |
Related |
NIDA
| 12-23-2020 |
01-26-2021 |
02-27-2021 |
R43/R44 |
Novel Approaches to Decrease Stigma of Substance Use Disorders in order to Facilitate Prevention, Treatment, and Support During Recovery (R41/R42 - Clinical Trials Optional) |
RFA-DA-21-015 |
Related |
NIDA
| 12-23-2020 |
01-26-2021 |
02-27-2021 |
R41/R42 |
Digital Technologies to Address the Social Determinants of Health in Context of Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional) |
RFA-DA-21-031 |
Related |
NIDA
| 12-22-2020 |
12-26-2020 |
02-27-2021 |
R41/R42 |
New Chemistries for Un-drugged Targets through A Specialized Platform for Innovative Research Exploration (ASPIRE) Collaborative Research Program (UG3/UH3 Clinical Trials Not Allowed) |
RFA-TR-21-001 |
Related |
NCATS
| 12-10-2020 |
06-08-2021 |
07-09-2021 |
UG3/UH3 |
Virtual Approaches Towards New Chemistries for Un-drugged Targets through A Specialized Platform for Innovative Research Exploration (ASPIRE) Collaborative Research Program (U18 Clinical Trials Not Allowed) |
RFA-TR-21-002 |
Related |
NCATS
| 12-10-2020 |
06-08-2021 |
07-09-2021 |
U18 |
Aging Effects on Osteoimmunology (R01 Clinical Trials Not Allowed) |
RFA-AG-22-002 |
Related |
NIA
| 12-10-2020 |
05-15-2021 |
06-16-2021 |
R01 |
Application of Artificial Intelligence and Machine Learning for Advancing Environmental Health Sciences (R41 Clinical Trial Not Allowed) |
RFA-ES-21-003 |
Related |
NIEHS
| 12-10-2020 |
02-28-2021 |
03-30-2021 |
R41 |
Application of Artificial Intelligence and Machine Learning for Advancing Environmental Health Sciences (R43 Clinical Trial Not Allowed) |
RFA-ES-21-002 |
Related |
NIEHS
| 12-10-2020 |
02-28-2021 |
03-30-2021 |
R43 |
NIAMS Centers of Research Translation (CORT) (P50 - Clinical Trial Not Allowed) |
RFA-AR-22-001 |
Related |
NIAMS
| 12-09-2020 |
04-11-2021 |
05-12-2021 |
P50 |
Mood Disorders in People Living with HIV: Mechanisms and Pathways (R21 Clinical Trial Optional) |
RFA-MH-21-117 |
Related |
NIMH
| 12-09-2020 |
02-10-2021 |
03-11-2021 |
R21 |
Mood Disorders in People Living with HIV: Mechanisms and Pathways (R01 Clinical Trial Optional) |
RFA-MH-21-116 |
Related |
NIMH
| 12-09-2020 |
02-10-2021 |
03-11-2021 |
R01 |
Cellular Cancer Biology Imaging Research (CCBIR) Program (U54, Clinical Trial Not Allowed) |
RFA-CA-21-002 |
Related |
NCI
| 12-09-2020 |
02-18-2021 |
03-19-2021 |
U54 |
NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional) |
RFA-RM-20-022 |
Related |
RMOD
| 12-08-2020 |
01-28-2021 |
03-02-2021 |
U54 |
NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Coordination and Evaluation Center (U24 Clinical Trial Not Allowed) |
RFA-RM-20-023 |
Related |
RMOD
| 12-08-2020 |
01-29-2021 |
04-24-2021 |
U24 |
Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional) |
RFA-CA-21-019 |
Related |
NCI
| 12-02-2020 |
05-09-2021 |
11-19-2021 |
U24 |
Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional) |
RFA-CA-21-018 |
Related |
NCI
| 12-02-2020 |
05-08-2021 |
11-18-2021 |
U01 |
Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional) |
RFA-CA-21-017 |
Related |
NCI
| 12-02-2020 |
05-08-2021 |
11-18-2021 |
R01 |
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) |
RFA-CA-21-016 |
Related |
NCI
| 12-02-2020 |
05-08-2021 |
11-18-2021 |
U24 |
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) |
RFA-CA-21-015 |
Related |
NCI
| 12-02-2020 |
05-08-2021 |
11-18-2021 |
U24 |
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) |
RFA-CA-21-014 |
Related |
NCI
| 12-02-2020 |
05-08-2021 |
11-18-2021 |
U01 |
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) |
RFA-CA-21-013 |
Related |
NCI
| 12-02-2020 |
05-08-2021 |
11-18-2021 |
R21 |
Summer Institute for Research Education in Biostatistics and Data Science (R25 Clinical Trial Not Allowed) |
RFA-HL-22-009 |
Related |
NHLBI
| 11-30-2020 |
02-08-2021 |
03-09-2021 |
R25 |
Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed) |
RFA-CA-21-001 |
Related |
NCI
| 11-25-2020 |
02-10-2021 |
03-25-2021 |
R42 |
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) |
RFA-CA-21-008 |
Related |
NCI
| 11-24-2020 |
01-22-2021 |
09-30-2021 |
U01 |
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional) |
RFA-CA-21-009 |
Related |
NCI
| 11-24-2020 |
01-22-2021 |
09-30-2021 |
U54 |
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) |
RFA-CA-21-010 |
Related |
NCI
| 11-24-2020 |
01-22-2021 |
09-30-2021 |
U2C |
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) |
RFA-CA-21-011 |
Related |
NCI
| 11-24-2020 |
01-22-2021 |
09-30-2021 |
P01 |